Mark Kris, MD
The William and Joy Ruane Chair in Thoracic Oncology
Lead Physician, MSKCC-IBM Watson Collaboration
Memorial-Sloan Kettering Cancer Center
Professor of Medicine
Weill Cornell Medical College
Dr. Kris is a specialist in lung cancer, thymoma, and neuroendocrine tumors arising in the chest. He is particularly interested in developing strategies to choose treatments for patients based on molecular characteristics of their tumor specimens. His research includes: the evaluation of new anticancer agents (particularly those targeting lung cancer), multimodality therapy (using surgery, radiation and drugs together to improve outcomes for individuals with thoracic cancers), and the testing of medicines to prevent nausea and emesis.
After receiving his medical degree from the Weill Cornell Medical College, Dr. Kris served as Chief Medical Resident and Fellow in Medical Oncology at Memorial Sloan-Kettering Cancer Center, and was previously Chief of the Thoracic Oncology Service. He is author or coauthor of 234 original scientific publications. Dr. Kris holds memberships in the American Association for Cancer Research, the American Society of Clinical Oncology, and the International Association for the Study of Lung Cancer. He is a member of the guideline panels on non-small cell lung cancer and antiemetics for the National Comprehensive Cancer Center Network. He serves as co-chair of the American Society of Clinical Oncology guideline panel for adjuvant chemotherapy and radiation for non-small cell lung cancer. He headed the Antiemetic Guideline Panel for the 2006 update for the American Society of Clinical Oncology. In addition, he is a Fellow of the American College of Physicians and the American College of Chest Physicians. Dr. Kris serves on the Medical Advisory Boards of Cancer Care, Inc. and Uniting Against Lung Cancer. He received the American Society of Clinical Oncology Humanitarian Award in 2011.